Dr. HILAL KURTOGLU GUMUSEL

• 2008Istanbul Science University Cardiology
• 2002Istanbul University Istanbul Faculty of Medicine

Experience

• 2017Acıbadem Health Group
• 2010 – 2017Private Erdem Hospital
• 2009 – 2010Cankiri State Hospital
• 2003 – 2008Istanbul Science University Florence Nightingale Hospital

• Turkish Medical Association
• European Society of Cardiology
• Turkish Cardiology Association

• Endothelial dysfunction and cardiovascular risk factors.Arch Turk Soc Cardiol H. Kurtoğlu Gümüşel, ABCatakoğlu, Ö.Yıldırımtürk, S.Yurdakul, F.Helvacıoğlu, M.Ziyrek, R.Hanavdeoğlulları, V.Aytekin, S.Aytekin
• Marfan Syndrome and Ascending Aorta Disease ReviewTürkiye Clinics Cardiovascular Surgery Aortic Surgery Special Issue Bilgen F, Hastaoğlu İ.O, Toköz H, Kurtoğlu Gümüşel H.
• The influence of aspirin resistance on non-fatal coronary events following percutaneous coronary interventionsArch Med Sci A B. Catakoglu, S. Aytekin, H. Celebi, M. Sener, H. Kurtoglu Gümüşel, C. Demiroglu, V. Aytekin.
• Does the metabolic syndrome or its components affect the outcome of percutaneous nephrolithotomy?Journal of Endourology. Tefekli A, Kurtoglu Gümüşel H, Tepeler K, Karadag MA, Kandrali E, Sari E, Baykal M, Muslumanoglu AY.
• The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries.Cardiovascular Revascularization Medicine. Celebi H, Catakoglu AB, Kurtoglu Gumusel H, Sener M, Hanavdelogullari R, Demiroglu C, Aytekin V, Aytekin S.
• Common variants in the ATP-binding cassette transporter 1 gene with decreased HDL-cholesterol levels and coronary artery disease.Archives of Medical Research. Catakoglu AB, Duman BS, Kurtoglu Gumusel H, Ersoz M, Sener M, Celebi H, Cagatay P, Aytekin V, Aytekin S.